Applied BioCode Corporation (TPE:6598)
Taiwan
· Delayed Price · Currency is TWD 19.90
+0.50 (2.58%)
May 12, 2025, 1:30 PM CST
Applied BioCode Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
| Cash & Equivalents | 605.96 | 413.19 | 831.32 | 646.07 | 847.91 | Upgrade
|
| Short-Term Investments | 251.53 | 191.62 | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 857.49 | 604.82 | 831.32 | 646.07 | 847.91 | Upgrade
|
| Cash Growth | 41.78% | -27.25% | 28.67% | -23.80% | 180.14% | Upgrade
|
| Receivables | 45.02 | 51.04 | 70.81 | 67.81 | 49.47 | Upgrade
|
| Inventory | 190.07 | 174.97 | 106.68 | 101.37 | 106.43 | Upgrade
|
| Other Current Assets | 11.71 | 6.53 | 5.48 | 11.2 | 17.26 | Upgrade
|
| Total Current Assets | 1,104 | 837.36 | 1,014 | 826.45 | 1,021 | Upgrade
|
| Property, Plant & Equipment | 98.79 | 131.14 | 169.62 | 162.77 | 171.52 | Upgrade
|
| Other Intangible Assets | 1.8 | 6.02 | 10.38 | 13.43 | 17.2 | Upgrade
|
| Long-Term Deferred Tax Assets | 3.11 | 4.5 | 3.99 | 3.51 | 4.6 | Upgrade
|
| Other Long-Term Assets | 6.92 | 14.19 | 14.18 | 12.8 | 12.83 | Upgrade
|
| Total Assets | 1,215 | 993.21 | 1,212 | 1,019 | 1,227 | Upgrade
|
| Accounts Payable | 6.44 | 2.58 | 8.73 | 9.43 | 27.6 | Upgrade
|
| Accrued Expenses | 35.63 | 32.08 | 35.06 | 26.11 | 30.3 | Upgrade
|
| Current Portion of Leases | 17.26 | 16.35 | 15.66 | 14.2 | 12.7 | Upgrade
|
| Current Income Taxes Payable | 2.53 | 0.47 | 1.5 | 4.18 | - | Upgrade
|
| Current Unearned Revenue | 54.59 | 43.25 | 22.77 | 1.99 | 1.96 | Upgrade
|
| Other Current Liabilities | 13.38 | 6.84 | 3.91 | 4.05 | 5.25 | Upgrade
|
| Total Current Liabilities | 129.83 | 101.56 | 87.63 | 59.95 | 77.8 | Upgrade
|
| Long-Term Leases | 2.27 | 18.08 | 33.45 | 44.56 | 48.73 | Upgrade
|
| Long-Term Unearned Revenue | 200.87 | 208.08 | 271.33 | 7.99 | 9.09 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 3.11 | 4.5 | 3.99 | 3.51 | 4.6 | Upgrade
|
| Total Liabilities | 336.07 | 332.22 | 396.38 | 116.01 | 140.23 | Upgrade
|
| Common Stock | 1,028 | 817.68 | 817.63 | 817.29 | 816.39 | Upgrade
|
| Additional Paid-In Capital | 272.28 | 43.81 | 359.24 | 351.58 | - | Upgrade
|
| Retained Earnings | -453.97 | -193.16 | -349.93 | -165.2 | -1,052 | Upgrade
|
| Comprehensive Income & Other | 32.65 | -7.34 | -10.88 | -100.71 | 1,323 | Upgrade
|
| Shareholders' Equity | 878.83 | 660.99 | 816.07 | 902.96 | 1,087 | Upgrade
|
| Total Liabilities & Equity | 1,215 | 993.21 | 1,212 | 1,019 | 1,227 | Upgrade
|
| Total Debt | 19.52 | 34.43 | 49.11 | 58.76 | 61.43 | Upgrade
|
| Net Cash (Debt) | 837.96 | 570.39 | 782.21 | 587.31 | 786.48 | Upgrade
|
| Net Cash Growth | 46.91% | -27.08% | 33.18% | -25.32% | 368.20% | Upgrade
|
| Net Cash Per Share | 9.25 | 6.98 | 9.57 | 7.19 | 10.14 | Upgrade
|
| Filing Date Shares Outstanding | 102.79 | 81.77 | 81.76 | 81.73 | 81.64 | Upgrade
|
| Total Common Shares Outstanding | 102.79 | 81.77 | 81.76 | 81.73 | 81.64 | Upgrade
|
| Working Capital | 974.46 | 735.8 | 926.66 | 766.5 | 943.28 | Upgrade
|
| Book Value Per Share | 8.55 | 8.08 | 9.98 | 11.05 | 13.31 | Upgrade
|
| Tangible Book Value | 877.03 | 654.97 | 805.69 | 889.52 | 1,070 | Upgrade
|
| Tangible Book Value Per Share | 8.53 | 8.01 | 9.85 | 10.88 | 13.10 | Upgrade
|
| Machinery | 78.54 | 70.92 | 67.91 | 91.96 | 81.71 | Upgrade
|
| Construction In Progress | - | 1.4 | 17.9 | 1.01 | - | Upgrade
|
| Leasehold Improvements | 75.3 | 70.79 | 52.29 | 46.71 | 44.37 | Upgrade
|
Updated Mar 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.